Fostemsavir Tris (BMS-663068 trisaminomethane or tromethamine or THAM) is the trisaminomethane salt of Fostemsavir (BMS663068; BMS-663068; Rukobia) which is an anti-HIV medication marketed in 2020. Fostemsavir is the phosphonooxymethyl prodrug of BMS-626529 which is a novel attachment inhibitor that targets HIV-1 gp120 and prevents its binding to CD4+ T cells.

纯度：≥98%

CAS：864953-39-9